BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//NIA IMPACT Collaboratory - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://impactcollaboratory.org
X-WR-CALDESC:Events for NIA IMPACT Collaboratory
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200220T120000
DTEND;TZID=America/New_York:20200220T130000
DTSTAMP:20260509T153750
CREATED:20200107T234223Z
LAST-MODIFIED:20200219T212317Z
UID:2441-1582200000-1582203600@impactcollaboratory.org
SUMMARY:Grand Rounds: Modifications and waivers of informed consent in pragmatic clinical trials
DESCRIPTION:Jason Karlawish\, MD\nProfessor of Medicine\, Medical Ethics and Health Policy\, and Neurology\nCo-Director\, Penn Memory Center\, University of Pennsylvania \nThursday\, February 20\, 2020\n12:00 – 1:00 pm EST\n \nJason Karlawish\, MD is a professor of medicine\, medical ethics and health policy\, and neurology at Penn and cares for patients at the Penn Memory Center\, which he co-directs. His research focuses on issues at the intersections of bioethics\, aging and the neurosciences. He leads the Penn Program for Precision Medicine for the Brain (P3MB). P3MB developed standards for Alzheimer’s disease biomarker disclosure and investigates the clinical impacts of this knowledge on persons and their families. He has investigated the psychological and ethical implications of biomarker-based Alzheimer’s disease diagnostics and treatments\, informed consent\, quality of life\, research and treatment decision making\, stigma and voting by persons with cognitive impairment and residents of long term care facilities. \n  \n  \nZoom Conferencing \nJoin from PC\, Mac\, iOS or Android: https://hebrewseniorlife.zoom.us/j/5479652617     \nDial-In:    +1 646 876 9923 (US Toll) or +1 669 900 6833 (US Toll) \nMeeting ID:  547 965 2617
URL:https://impactcollaboratory.org/event/modifications-and-waivers-of-informed-consent-in-pragmatic-clinical-trials/
CATEGORIES:Grand Rounds
END:VEVENT
END:VCALENDAR